Free fatty acids: Mediators of insulin resistance and atherosclerosis;Vrije vetzuren: Mediatoren van insulineresistentie en atherosclerose

Nederlands Tijdschrift voor Geneeskunde

Volumn 146, Issue 3, 2002, Pages 103-109

  Castro Cabezas, M ^a   Erkelens, D W ^a   Van Dijk, H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHYLOMICRON; COMPLEMENT COMPONENT C3; FATTY ACID; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIOGLITAZONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADIPOCYTE; ARTICLE; ATHEROSCLEROSIS; COMPLEMENT ACTIVATION; DNA TRANSCRIPTION; DRUG EFFECT; FATTY ACID METABOLISM; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN METABOLISM; MEDIATOR RELEASE; PATHOGENESIS; POSTPRANDIAL STATE;

ARTERIOSCLEROSIS; COMPLEMENT C3; FATTY ACIDS, NONESTERIFIED; HUMANS; INSULIN RESISTANCE; LIPOPROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLES; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 0037132808     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994
2. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations
3. Distinct risk profiles of early and advanced atherosclerosis: Prospective results from the Bruneck Study
4. Cardiovascular disease mortality in familial forms of hypertriglyceridemia
5. Serumtriglyceriden als risicofactor voor atherosclerose
6. Triglyceridedagprofielen bij 30 jonge gezonde mannen als functie van voeding, nuchtere triglycerideconcentraties, lichaamssamenstelling en insuline-gevoeligheid
7. Triglycerides and atherosclerosis: To feast or fast
8. Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia
9. Impaired chylomicron remnant clearance in familial combined hyperlipidemia
10. Familial lipoprotein disorders in patients with premature coronary artery disease
11. Chylomicrons and chylomicron remnants in coronary artery disease: A case-control study
12. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
13. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: Case control study over three years
14. In vivo evidence of defective postprandial and postabsorptive free fatty acid metabolism in familial combined hyperlipidemia
15. Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein
16. The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis
17. An enzyme in human blood plasma that inactivates bradykinin and kallidins
18. Regulation of plasma fatty acid metabolism
19. C3a(desArg) does not bind to and signal through the human C3a receptor
20. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction
21. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries
22. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
23. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
24. C-reactive protein, cardiovascular risk factors and the association with myocardial infarction in men
25. Genetics of inflammation and risk of coronary artery disease: The central role of interleukin-6
26. Erythrocyte sedimentation rate: A possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality
27. Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men
28. Regulatory interactions between lipids and carbohydrates: The glucose fatty acid cycle after 35 years
29. Effect of elevated free fatty acids on glucose oxidation in normal humans
30. Mechanisms of fatty acid-induced inhibition of glucose uptake
31. Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man
32. Cellular mechanisms of insulin resistance in humans
33. Acute in vitro production of acylation stimulating protein in differentiated human adipocytes
34. Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation
35. Systematic review on the risk and benefit of different cholesterol-lowering interventions
36. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study
37. Overgewicht. I. Prevalenties en trends
38. Bodymass index and mortality in a prospective cohort of U.S. adults
39. RXR agonists activate PPARalpha-inducible genes, lower triglycerides, and raise HDL levels in vivo
40. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazonc
41. Regulation of lipoprotein metabolism by thiazolidinediones; Occurs through a distinct but complementary mechanism relative to fibrates
42. Assessment of human muscle glycogen synthesis and total glucose content by in vivo 13C MRS
43. Thiazolidinediones
44. PPARgamma, the ultimate thrifty gene
45. Troglitazone: A review of its use in the management of type 2 diabetes mellitus
46. Hepatic failure in a patient taking rosiglitazone
47. Hepatocellular injury in a patient receiving rosiglitazone. A case report